Christopher F Rowley MD
Assistant Professor, Medicine-Beth Israel Deaconess Medical Center, Harvard Medical School
Join to View Full Profile
110 Francis Street-Suite GBBeth Israel Medical CenterBoston, MA 02215
Phone+1 617-632-7706
Fax+1 617-632-7626
Dr. Rowley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 2002 - 2005
University of ColoradoResidency, Internal Medicine, 1997 - 2000
State University of New York Downstate Medical Center College of MedicineClass of 1997
Certifications & Licensure
MA State Medical License 2002 - 2026
CO State Medical License 1999 - 2003
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 6 citationsBacteriophage therapy and current delivery strategies for orthopedic infections: A SCOPING review.Jason Young, Sang W Lee, Mohammad J Shariyate, Alexandria Cronin, John J Wixted
The Journal of Infection. 2024-03-01 - 22 citationsSignificant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus...David H Canaday, Oladayo A Oyebanji, Debbie Keresztesy, Michael Payne, Dennis Wilk
Clinical Infectious Diseases. 2022-08-24 - 70 citationsTecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States.Wilfredo R Matias, Jacob M Koshy, Ellen H Nagami, Victor Kovac, Letumile R Moeng
Open Forum Infectious Diseases. 2022-08-01
Press Mentions
From the Lab to COVID Front LinesMarch 31st, 2020
Message on Opioids from HIV Docs to Colleagues Is Clear: Get Training, Prescribe Buprenorphine, Save LivesOctober 17th, 2018
Serious Heart Condition Becoming Common in Young Injection Drug UsersApril 12th, 2018
Grant Support
- Novel Strategy For HIV Drug Resistance Monitoring In Developing Countries.National Institute Of Allergy And Infectious Diseases2011
- Novel Monitoring Strategy And Fitness Analysis Of Transmitted HIV Drug ResistanceNational Institute Of Allergy And Infectious Diseases2010
- Nevirapine Resistance In Women WHO Received Nevirapine For Pmtct HIVNational Institute Of Allergy And Infectious Diseases2005–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
